查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722989

2025 年至 2033 年糖组学市场规模、份额、趋势及预测（按产品、应用、最终用户和地区）

Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球糖组学市场规模价值 17 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 45 亿美元，2025 年至 2033 年的复合年增长率为 10.61%。北美目前占据市场主导地位，2024 年的市占率将超过 39.1%。由于慢性病发病率的上升、对糖工程技术的关注度的提高以及参与药物和生物製剂的合约研究组织 (CRO) 数量的增加，糖组学市场份额正在上升。

糖组学是一门专注于全面研究生物系统中的碳水化合物，特别是聚醣的科学领域。其目的是了解聚醣的结构、组成和功能，以及它们与其他生物分子的相互作用。透过分析醣组，研究人员可以确定聚醣如何影响生物过程并导致健康和疾病。这个跨学科领域结合了化学、生物化学、分子生物学和资讯学的各个方面，以揭示聚醣结构和功能的复杂性。研究获得的见解对医学、药物开发、生物标记发现和个人化治疗等各个领域都有影响。

全球市场主要受到慢性病日益普及的推动。此外，由于糖工程涉及对聚醣的修饰或操纵，以用于各种应用，包括治疗、疫苗和生物技术，因此对糖工程的日益关注正在支撑市场。除此之外，各国政府、研究机构和私人投资者都认识到糖组学在推动医疗保健和生物技术方面的潜力，并提供投资进行深入研究、开发新技术、探索基于糖组学的产品商业化，从而推动市场发展。此外，它在世界各地的教育和培训领域越来越受欢迎。此外，参与药物和生物製剂开发和生产的合约研究组织（CRO）数量的不断增长也促进了市场的成长。其他因素，如製药业的扩张、临床试验数量的增加以及医疗保健基础设施的进步，也正在影响市场。

糖组学市场趋势/驱动因素：

增加研发活动

市场正在经历研发活动的显着成长。随着对聚醣在各种生物过程中所扮演的关键角色的了解不断加深，人们对研究和操纵这些分子的兴趣也日益增加。研究人员和製药公司正在投资研究，探索聚醣在药物发现、个人化医疗和诊断方面的潜在应用。此外，分析技术和技术的不断进步也推动着研究范围的不断扩大。此外，学术界、产业界和研究机构之间的合作推动了糖组学研发的发展。这些合作汇集了不同的专业知识和资源，促进了创新并加速了基于糖组学的产品的开发。此外，各利害关係人之间的协作努力有助于扩展知识、开发新技术以及将研究成果转化为实际应用。

个人化医疗需求不断成长

个人化医疗正日益受到重视，其目的是根据患者的基因组成和具体特征为其量身定制医疗方案。它在个人化医疗中发挥关键作用，因为聚醣与各种疾病有关，并且可以作为诊断和预后的潜在生物标记。分析和了解患者的血糖水平的能力有助于开发有针对性的治疗方法和更精准的医疗干预措施。此外，糖组学分析技术（如糖微阵列和糖测序）的进步促进了疾病特异性糖特征的识别。这些发现为基于聚醣的诊断、个人化治疗和伴随诊断的发展带来了希望，进一步推动了对糖组学研究和产品的需求。

日益关註生物标誌物的发现

糖组学在生物标记发现领域引起了广泛关注。聚醣已显示出作为各种疾病（包括癌症、心血管疾病和传染病）的生物标记的巨大潜力。生物标记在疾病诊断、预后和监测治疗效果中发挥着至关重要的作用。此外，人们对生物标记发现的日益关注推动了研究的需求，因为识别可靠和特定的生物标记对于改善疾病检测、患者分层和治疗选择至关重要。此外，将糖组学整合到生物标记发现流程中，有可能彻底改变诊断方式并实现早期干预，从而推动整个市场的成长。此外，该研究还提供了一个独特的机会来识别与不同疾病相关的特定聚醣模式或变化。透过研究个体或患者群体的醣组，研究人员可以揭示可作为诊断或预后生物标记的疾病特异性聚醣特征。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球糖组学市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 酵素
    • 关键部分
      • 糖苷酶
      • 糖基转移酶
      • 神经氨酸酶
      • 唾液酸转移酶
      • 其他的
  • 仪器
    • 关键部分
      • 质谱仪
      • 高效液相层析
      • 基质辅助雷射解吸电离飞行时间质谱法
      • 阵列系统
      • 其他的
  • 套件
    • 关键部分
      • 聚醣标记试剂盒
      • 聚醣纯化试剂盒
      • 聚醣释放试剂盒
      • 其他的
  • 试剂
    • 关键部分
      • 糖蛋白
      • 单醣
      • 寡糖
      • 其他的

第七章：市场区隔：依应用

  • 药物研发
  • 诊断
  • 其他的

第八章：市场区隔：按最终用户

  • 学术和研究机构
  • 製药和生物技术公司
  • 合约研究组织（CRO）

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Danaher Corporation
    • Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
    • Merck KGaA
    • New England Biolabs
    • RayBiotech Life Inc.
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112025A5689

The global glycomics market size was valued at USD 1.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.5 Billion by 2033, exhibiting a CAGR of 10.61% from 2025-2033. North America currently dominates the market, holding a market share of over 39.1% in 2024. The glycomics market share is rising due to the growing incidence of chronic diseases, rising focus on glycoengineering techniques, and increasing number of contract research organizations (CROs) involved in drug and biologics.

Glycomics is a scientific field that focuses on the comprehensive study of carbohydrates, specifically glycans, in biological systems. It aims to understand the structure, composition, and functions of glycans, as well as their interactions with other biomolecules. By analyzing the glycome, researchers can determine how glycans influence biological processes and contribute to health and disease. This interdisciplinary field combines aspects of chemistry, biochemistry, molecular biology, and informatics to unravel the complexities of glycan structures and functions. The insights gained from the research have implications across various domains, including medicine, drug development, biomarker discovery, and personalized therapeutics.

The global market is primarily driven by the growing prevalence of chronic diseases. Moreover, the increasing focus on glycoengineering is supporting the market as glycoengineering involves the modification or manipulation of glycans for various applications, including therapeutics, vaccines, and biotechnology. Apart from this, Governments, research organizations, and private investors are recognizing the potential of glycomics in advancing healthcare and biotechnology and are providing investments to conduct in-depth studies, develop new technologies, and explore the commercialization of glycomics-based products, providing a boost to the market. Furthermore, it is gaining popularity in the field of education and training worldwide. Additionally, the growing number of contract research organizations (CROs) involved in drug and biologics development and production is augmenting the market growth. Other factors, such as expanding pharmaceutical industry, increasing number of clinical trials, and advancements in healthcare infrastructure, are also influencing the market.

Glycomics Market Trends/Drivers:

Increasing Research and Development Activities

The market is experiencing a significant boost in research and development (R&D) activities. The growing understanding of the crucial roles played by glycans in various biological processes has increased interest in studying and manipulating these molecules. Researchers and pharmaceutical companies are investing in research to explore the potential applications of glycans in drug discovery, personalized medicine, and diagnostics. Moreover, the expanding scope of the research is driven by continuous advancements in analytical techniques and technologies. Furthermore, collaborations between academia, industry, and research institutions have fueled the growth of glycomics R&D. These collaborations bring together diverse expertise and resources, fostering innovation and accelerating the development of glycomics-based products. Additionally, the collaborative efforts between various stakeholders contribute to the expansion of knowledge, development of new technologies, and translation of research findings into practical applications.

Rising Demand for Personalized Medicine

Personalized medicine, which aims to tailor medical treatments to individual patients based on their genetic makeup and specific characteristics, is gaining prominence. It plays a pivotal role in personalized medicine as glycans have been implicated in various diseases and can serve as potential biomarkers for diagnostics and prognostics. The ability to analyze and understand the glycome of patients can enable the development of targeted therapies and more precise medical interventions. In addition, the advancements in glycomics profiling technologies, such as glycan microarrays and glycan sequencing, have facilitated the identification of disease-specific glycan signatures. These discoveries hold promise for the development of glycan-based diagnostics, personalized therapeutics, and companion diagnostics, further fueling the demand for glycomics research and products.

Increasing Focus on Biomarker Discovery

Glycomics has gained significant attention in the field of biomarker discovery. Glycans have shown promising potential as biomarkers for various diseases, including cancer, cardiovascular disorders, and infectious diseases. Biomarkers play a crucial role in disease diagnosis, prognosis, and monitoring treatment efficacy. Moreover, the growing focus on biomarker discovery has propelled the demand for research, as the identification of reliable and specific biomarkers is crucial for improving disease detection, patient stratification, and treatment selection. Furthermore, the integration of glycomics into biomarker discovery pipelines has the potential to revolutionize diagnostics and enable early intervention, driving the growth of the overall market. Also, the research offers a unique opportunity to identify specific glycan patterns or alterations associated with different diseases. By studying the glycome of individuals or patient cohorts, researchers can unveil disease-specific glycan signatures that can serve as diagnostic or prognostic biomarkers.

Glycomics Industry Segmentation:

Breakup by Product:

  • Enzymes
  • Glycosidases
  • Glycosyltransferases
  • Neuraminidases
  • Sialyltransferases
  • Others
  • Instruments
  • Mass Spectrometers
  • HPLC
  • MALDI-TOF
  • Array systems
  • Others
  • Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Glycan Release Kits
  • Others
  • Reagents
  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides
  • Others

Enzymes equipment dominates the market

On the basis of the product, enzymes represent the largest product segment within the market. Enzymes play a crucial role in research and applications by facilitating the analysis and manipulation of glycans. Enzymes, such as glycosidases, glycosyltransferases, and glycosyl hydrolases, are utilized in various workflows, including glycan release, structural analysis, and glycan modification. Moreover, enzymes are essential for the enzymatic cleavage of glycans from glycoproteins or glycolipids, enabling the analysis of liberated glycans. The demand for enzymes in research and applications is driven by the growing need for robust and efficient enzymatic tools. Researchers and scientists rely on enzymes to accurately and selectively manipulate glycans, enabling comprehensive glycomics analysis and the development of glycan-based products. Additionally, advancements in enzyme engineering and optimization have led to the development of highly specific and efficient enzymes, further enhancing their utility in glycomics research.

Breakup by Application:

  • Drug Discovery and Development
  • Diagnostics
  • Others

Drug discovery and development hold the largest share in the market

On the basis of application, drug discovery and development represent the largest segment within the overall market. It plays a crucial role in advancing drug discovery and development processes by providing insights into the role of glycans in disease mechanisms, drug efficacy, and safety. Glycans are involved in various biological processes and have been linked to numerous diseases, including cancer, cardiovascular disorders, and infectious diseases. Understanding the glycan profiles and their interactions with proteins and cells is essential for identifying potential therapeutic targets and designing effective drugs. Moreover, the integration with drug discovery and development processes has led to the development of glycan-based therapies, companion diagnostics, and improved drug screening platforms. Also, the focus on targeting glycans in drug discovery and development has driven the demand for research and technologies, making it the largest application segment within the market.

Breakup by End User:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

Academic and research institutes hold the largest share in the market

Academic and research institutes represent the largest segment of the market. They play a vital role in driving research and advancements in the field. These institutions serve as the primary hubs for scientific research, knowledge generation, and innovation in the field. They are home to leading scientists, researchers, and experts who are actively involved in studying and exploring the complexities of glycans. These institutions also provide the necessary infrastructure, funding, and collaborative opportunities to support the research. They often house state-of-the-art laboratories equipped with advanced analytical instruments and technologies, enabling comprehensive glycan analysis and profiling. Furthermore, academic and research institutes contribute significantly to expanding the knowledge base through publications, scientific conferences, and collaborations. They foster interdisciplinary research collaborations, bringing together experts from various fields such as chemistry, biology, bioinformatics, and medicine.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest glycomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the market. North America is home to several renowned academic institutions, research organizations, and biotechnology companies that have made significant contributions to the research. These institutions have robust research infrastructure, state-of-the-art laboratories, and well-established collaborations, facilitating cutting-edge studies and innovation. Moreover, the region has a well-developed healthcare and biopharmaceutical sector, which drives the demand for research and applications. The presence of major pharmaceutical companies and biotech firms in North America leads to significant investments in the research for drug discovery, personalized medicine, and the development of glycan-based therapeutics. Furthermore, the region has a favorable regulatory environment and strong intellectual property protections that encourage innovation and commercialization of glycomics-based products. The region's well-defined regulatory frameworks provide clarity and guidance for research, ensuring the safety and efficacy of glycan-based diagnostics and therapeutics.

Competitive Landscape:

Companies in the market are involved in various activities related to glycomics research, product development, and commercialization. Several major companies are investing in research and development to advance the understanding of glycans, develop new technologies, and explore applications in various fields. They conduct studies to uncover the roles of glycans in disease mechanisms, identify glycan biomarkers, and understand glycan-protein interactions. Moreover, the companies in the market develop and manufacture products that support the research. This includes enzymes, kits, reagents, and instruments used in glycan analysis, glycan profiling, and glycan modification. These products help researchers in academia, pharmaceutical companies, and research institutes carry out glycomics experiments and investigations. Additionally, some companies focus on translating research into commercial applications. They develop and market glycan-based products for various industries, such as biopharmaceuticals, diagnostics, and nutraceuticals.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Asparia Glycomics
  • Bruker Corporation
  • Danaher Corporation
  • Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
  • Merck KGaA
  • New England Biolabs
  • RayBiotech Life Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation.

Recent Developments:

In June 2023, Agilent Technologies Inc. launched Agilent BioTek 406 FX washer dispenser, a compact instrument that combines multifunctional reagent dispensing and plate-washing capabilities. The BioTek 406 FX offers expanded liquid handling features designed for integration into automated systems and standalone benchtop use.

In March 2023, Waters Corporation launched Next-Generation Alliance iS HPLC System aimed at reducing Up to 40% of Common Lab Errors. This new product helps laboratories manage operational risk, mitigate disruptions, and increase overall productivity.

In September 2022, Thermo Fisher Scientific Inc. launched the DynaSpin(TM) Single-Use Centrifuge system2. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. It also improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process.

Key Questions Answered in This Report

  • 1.How big is the glycomics market?
  • 2.What is the future outlook of glycomics market?
  • 3.What are the key factors driving the glycomics market?
  • 4.Which region accounts for the largest glycomics market share?
  • 5.Which are the leading companies in the global glycomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Glycomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Enzymes
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Glycosidases
      • 6.1.2.2 Glycosyltransferases
      • 6.1.2.3 Neuraminidases
      • 6.1.2.4 Sialyltransferases
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Mass Spectrometers
      • 6.2.2.2 HPLC
      • 6.2.2.3 MALDI-TOF
      • 6.2.2.4 Array systems
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Kits
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Glycan Labeling Kits
      • 6.3.2.2 Glycan Purification Kits
      • 6.3.2.3 Glycan Release Kits
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Reagents
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Glycoproteins
      • 6.4.2.2 Monosaccharides
      • 6.4.2.3 Oligosaccharides
      • 6.4.2.4 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Academic and Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Asparia Glycomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 New England Biolabs
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 RayBiotech Life Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Shimadzu Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Waters Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Glycomics Market: Major Drivers and Challenges
  • Figure 2: Global: Glycomics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Glycomics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Glycomics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Glycomics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Glycomics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Glycomics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Glycomics (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Glycomics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Glycomics (Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Glycomics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Glycomics (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Glycomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Glycomics Industry: SWOT Analysis
  • Figure 78: Global: Glycomics Industry: Value Chain Analysis
  • Figure 79: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Glycomics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Glycomics Market: Competitive Structure
  • Table 7: Global: Glycomics Market: Key Players